Compared with the survival plot of patients among all SKCM, LAML, and LUAD, high expression of miR-708 presented a moderately better survival rate in patients with NRAS mutation from three different cancer types (Fig 5), especially in patients with LAML (Fig 5C) and LUAD (Fig 5E). Here, NRAS is linked to cancer.